Disease Associations with Anti-Neutrophil Cytoplasmic Antibodies

  • Charles D. Pusey
  • Gillian Gaskin
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 336)


The discovery of autoantibodies to components of neutrophil cytoplasm, widely known as anti-neutrophil cytoplasmic antibodies (ANCA), has led to great advances in the diagnosis and monitoring of patients with primary systemic vasculitis. The antigenic targets of ANCA have been identified as neutrophil granule constituents, and it appears that the specificity of the antibodies is associated with particular clinical characteristics. The presence of ANCA is associated with active disease, and rising concentrations may herald a relapse. There is evidence from in vitro studies that ANCA can activate neutrophils and lead to endothelial cell damage, suggesting that they may have a pathogenic role in vasculitis. More recently, ANCA have been described in a limited range of other diseases. The specificity of these autoantibodies is less well defined, but includes targets other than those recognised in systemic vasculitis. Data on their prevalence and their relationship to disease activity is conflicting, and there is no experimental evidence for pathogenicity.


Infective Endocarditis Giant Cell Arteritis Systemic Vasculitis Antineutrophil Cytoplasmic Antibody Relapse Polychondritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    G. Gaskin, and C. D. Pusey. 1992. Systemic vasculitis. in: “Oxford Textbook of Clinical Nephrology”. J. S. Cameron, A. M. Davison, J-P. Grunfeld, D. N. S. Kerr, and E. Ritz, editors. Oxford University Press, Oxford. 612–636.Google Scholar
  2. 2.
    D. J. Davies, J. E. Moran, J. F. Niall, and G. B. Ryan 1982. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Brit Med f285:606.Google Scholar
  3. 3.
    F. J. van der Woude, N. Rasmussen, S. Lobatto, A. Wiik, H. Permin, L. A. van Es, M. van der Giessen, G. K. van der Hem, and T. H. The 1985. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1: 425–429.PubMedCrossRefGoogle Scholar
  4. 4.
    C. O. S. Savage, C. G. Winearls, S. Jones, P. D. Marshall, and C. M. Lockwood 1987. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1: 1389–1393.PubMedCrossRefGoogle Scholar
  5. 5.
    R. J. Falk,and J. C. Jennette 1988. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651–1657.Google Scholar
  6. 6.
    R. Goldschmeding, C. E. van der Schoot, D. ten Bokkel Huinink, C. E. Hack, M. E. van den Ende, C. G. M. Kallenberg,and A. E. G. Kr. von dem Borne 1989. Wegener’s granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 84: 1577–1587.PubMedCrossRefGoogle Scholar
  7. 7.
    J. L. Niles, R. T. McCluskey, M. F. Ahmad, and M. Amin Arnaout 1989. Wegener’s granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 74: 1888–1893.PubMedGoogle Scholar
  8. 8.
    J. Lüdemann, B. Utecht, and W. L. Gross 1990. Anti-neutrophil cytoplasm antibodies in Wegener’s granulomatosis recognize an elastinolytic enzyme. JExp Med 171: 357–362.CrossRefGoogle Scholar
  9. 9.
    D. Campanelli, M. Melchior,Y. Yu, M. Nakata, H. Shuman, C. Nathan, and J. E. Gabay 1990. Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. JExpMed 172: 1709–1715.CrossRefGoogle Scholar
  10. 10.
    D. E. Jenne, J. Tschopp, J. Lüdemann, B. Utecht, and W. L. Gross 1990. Wegener’s autoantigen decoded. Nature 346: 520.PubMedCrossRefGoogle Scholar
  11. 11.
    R. J. Falk1990. ANCA-associated renal disease. Kidneylnt. 38: 998–1010.Google Scholar
  12. 12.
    P. Lesavre 1991. Antineutrophil cytoplasmic autoantibodies antigen specificity. Am JKid Dis 18: 159–163.Google Scholar
  13. 12a.
    U. Specks, C. L. Wheatley, T. J. McDonald, M. S. Rohrbach, and R. A. DeRemee 1989. Anticytoplasmic autoantibodies in the diagnostic and follow-up of Wegener’s granulomatosis. Mayo Clin Proc 64: 28–36.PubMedCrossRefGoogle Scholar
  14. 13.
    R. Goldschmeding, J. W. Cohen Tervaert, R. O. Gans, K. M. Dolman, M. E. van den Ende, M. C. Kuizinga, C. G. M Kallenberg, and A. E. K. von dem Borne 1990. Different immunological specificities and disease associations of c-ANCA and p-ANCA. Neth J Med 36: 114–116.PubMedGoogle Scholar
  15. 14.
    N. Rasmussen, C. Sjolin, B. Isakkson, P. Bygren, and J. Wieslander 1990. An ELISA for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). JImmunol Methods 127: 139–145.CrossRefGoogle Scholar
  16. 15.
    D. R. W. Jayne, S. Jones,A. Severn, S. Shaunak,J. Murphy, and C. M. Lockwood 1989. Severe pulmonary haemorrhage and systemic vasculitis in association with circulating anti-neutrophil cytoplasm antibodies of IgM class only. Clin. Nephro 132: 101–106.Google Scholar
  17. 16.
    V. L. M. Esnault, B. Soleimani, M. T. Keogan, A. A. Brownlee, D. R. W. Jayne, and C. M. Lockwood 1992. Association of IgM with IgG ANCA in patients presenting with pulmonary haemorrhage. Kidney Int 41: 1304–1310.PubMedCrossRefGoogle Scholar
  18. 17.
    J. W. Cohen Tervaert, R. Goldschmeding, J. D. Elema, A. E. von dem Borne, and C G Kallenberg 1991. Antimyeloperoxidase antibodies in Churg-Strauss syndrome. Thorax 46: 70–71.PubMedCrossRefGoogle Scholar
  19. 18.
    L. Nassberger, A. G. Sjoholm, H. Jonsson, G. Sturfelt,and A. Akesson 1990. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Imrnuno 181: 3803.Google Scholar
  20. 19.
    C. O. S. Savage, J. Tizard, D. R. W. Jayne, C. M. Lockwood, and M. J. Dillon 1989. Anti-neutrophil cytoplasm antibodies in Kawasaki syndrome. Arch Dis Child 64: 462.CrossRefGoogle Scholar
  21. 20.
    F. T. Saulsbury, P. R. Kirkpatrick, and W. K. Bolton 1991. IgA antineutrophil cytoplasmic antibody in Henoch-Schonlein Purpura. Am JNephro 111: 295–300.CrossRefGoogle Scholar
  22. 21.
    A. Wiik, E. Jensen, and J. Friis 1974. Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. Ann Rheum Dis 33: 515–522.PubMedCrossRefGoogle Scholar
  23. 22.
    A. Saxon, F. Shanahan, C. Landers, T Ganz, and S. Targan 1990. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. JAllergy Clin Immunol 86: 202–210.CrossRefGoogle Scholar
  24. 23.
    J. A. Rump, J. Scholmerich, V. Gross, M. Roth, R. Helfesrieder, A. Rautmann, J. Ludemann, W. L. Gross,and H. H. Peter 1990. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn’s disease. Immunobiology 181: 406–413.PubMedCrossRefGoogle Scholar
  25. 24.
    D. R. W. Jayne, P. D. Marshall, S. J. Jones,and C. M. Lockwood 1990. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Inl 37: 965–970.CrossRefGoogle Scholar
  26. 25.
    J. Wagner, K. Andrassy, and E. Ritz 1991. Is vasculitis in subacute bacterial endocarditis associated with ANCA? Lancet 337: 799–800.PubMedCrossRefGoogle Scholar
  27. 26.
    D. Sitara, and B. I. Hoffbrand 1990. Chronic bronchial suppuration and antineutrophil cytoplasmic antibody (ANCA) positive systemic vasculitis. Postgrad Med J 66: 669–671.Google Scholar
  28. 27.
    J. Efthimiou, G. Spickett, D. Lane, and A. Thompson 1991. Antineutrophil cytoplasmic antibodies, cystic fibrosis, and infection. Lancet 337: 1037–1038.PubMedCrossRefGoogle Scholar
  29. 28.
    R. J. Klaassen, R. Goldschmeding, K. M. Dolman, A. B. Vlekke, H. M. Weigel, J. K. Eeftinck Schattenkerk, J. W. Mulder, M. L. Westedt, and A. E. von dem Borne 1992. Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol 87: 24–30.PubMedCrossRefGoogle Scholar
  30. 29.
    G. Gaskin, C. O. S. Savage, J. J. Ryan, S.. Jones, A. J. Rees, C. M. Lockwood, and C. D. Pusey 1991. Antineutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 6: 689–694.PubMedCrossRefGoogle Scholar
  31. 30.
    J. W. Cohen Tervaert, F. J. van der Woude, A. S. Fauci, J. L. Ambrus, J. Velosa, W. F. Keane, S. Meijer, M. van der Giessen, T. H. The, G. K. van der Hem,and C. G. M. Kallenberg 1989. Association between active Wegener’s granulomatosis and anticytoplasmic antibodies. Arch. Intern. Med 149: 2461–2465.PubMedCrossRefGoogle Scholar
  32. 31.
    J. W. Cohen Tervaert, M. G. Huitema, R. W. Hene,W. J. Sluiter,T. H. The, G. K. van der Hem,and C. G. M. Kallenberg 1990. Prevention of relapses in Wegener’s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336: 709–711.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Charles D. Pusey
    • 1
  • Gillian Gaskin
    • 1
  1. 1.Renal Unit Department of Medicine Royal Postgraduate Medical SchoolHammersmith HospitalLondonUK

Personalised recommendations